Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company ...
Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
New Scientist on MSN
mRNA covid vaccines spark immune response that may aid cancer survival
An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Deborah Fuller, University of Washington (THE CONVERSATION) At a Sept. 4, 2025, ...
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...
Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback